MENU
+Compare
EXAS
Stock ticker: NASDAQ
AS OF
Dec 24, 02:00 PM (EDT)
Price
$58.11
Change
-$0.82 (-1.39%)
Capitalization
12.78B

EXAS Exact Sciences Corp Forecast, Technical & Fundamental Analysis

a developer of proprietary technologies for the detection of cancer

EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for EXAS with price predictions
Dec 23, 2024

EXAS in downward trend: price dove below 50-day moving average on December 12, 2024

EXAS moved below its 50-day moving average on December 12, 2024 date and that indicates a change from an upward trend to a downward trend. In of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 13, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on EXAS as a result. In of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for EXAS turned negative on December 18, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXAS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EXAS's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EXAS advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .

EXAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 208 cases where EXAS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.065) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (5.074) is also within normal values, averaging (43.338).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EXAS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EXAS is expected to report earnings to rise 57.10% to -32 cents per share on February 25

Exact Sciences Corp EXAS Stock Earnings Reports
Q4'24
Est.
$-0.33
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.25
Q1'24
Missed
by $0.12
Q4'23
Beat
by $0.17
The last earnings report on November 05 showed earnings per share of -20 cents, missing the estimate of -20 cents. With 485.08K shares outstanding, the current market capitalization sits at 12.78B.
A.I. Advisor
published General Information

General Information

a developer of proprietary technologies for the detection of cancer

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5505 Endeavor Lane
Phone
+1 608 284-5700
Employees
6600
Web
https://www.exactsciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
AAVE.X384.06195066.574980
+20.97%
Aave cryptocurrency
ASTR.X0.0630980.003131
+5.22%
Astar cryptocurrency
CTXC.X0.2863010.005931
+2.12%
Cortex cryptocurrency
REP.X0.5029130.002107
+0.42%
Augur cryptocurrency
POND.X0.018875-0.000185
-0.97%
Marlin cryptocurrency

EXAS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EXAS has been loosely correlated with QGEN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if EXAS jumps, then QGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXAS
1D Price
Change %
EXAS100%
-0.79%
QGEN - EXAS
55%
Loosely correlated
+0.34%
RGEN - EXAS
55%
Loosely correlated
+0.82%
FNA - EXAS
32%
Poorly correlated
+0.60%
ATEC - EXAS
29%
Poorly correlated
-2.46%
NAOV - EXAS
29%
Poorly correlated
-6.70%
More